{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T10:29:59Z","timestamp":1749032999595},"reference-count":46,"publisher":"American Society for Microbiology","issue":"8","license":[{"start":{"date-parts":[[2007,8,1]],"date-time":"2007-08-01T00:00:00Z","timestamp":1185926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Infect Immun"],"published-print":{"date-parts":[[2007,8]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>We designed an amebiasis subunit vaccine that is constructed by using four peptide epitopes of the galactose-inhibitable lectin heavy subunit that were recognized by intestinal secretory immunoglobulin A (IgA) antibodies from immune human subjects. These epitopes are contained in the region encompassing amino acids 758 to 1134 of the lectin heavy subunit, designated LC3. Baboons (<jats:italic>Papio anubis<\/jats:italic>) are natural hosts for<jats:italic>Entamoeba histolytica<\/jats:italic>; naturally infected baboons raised in captivity possess serum IgA antibodies to the same four LC3 epitopes as humans. Uninfected, seronegative baboons received four intranasal immunizations at 7-day intervals with the synthetic peptide vaccine (400, 800, or 1,600 \u03bcg per nostril) with cholera toxin (20 \u03bcg) as the adjuvant. As determined by an enzyme-linked immunosorbent assay (ELISA), each dose of the peptide vaccine elicited antipeptide serum IgA and IgG and intestinal IgA antibody responses in all six immunized baboons by day 28, 7 days after the last immunization (<jats:italic>P<\/jats:italic>, &lt;0.01 for each dose compared to the cholera toxin control). The peptide vaccine elicited serum IgG and intestinal IgA antibodies that recognized purified recombinant LC3 protein (<jats:italic>P<\/jats:italic>, &lt;0.008 and 0.02, respectively) and native lectin protein (<jats:italic>P<\/jats:italic>&lt; 0.01). In addition, an indirect immunofluorescence assay with whole trophozoites (<jats:italic>P<\/jats:italic>&lt; 0.01) and Western blot analysis confirmed that serum IgG antibodies from vaccinated baboons recognized native lectin protein on the surfaces of axenic<jats:italic>E. histolytica<\/jats:italic>trophozoites or from solubilized amebae. All four synthetic peptides were immunogenic; the vaccine elicited dose- and time-dependent responses, as determined by ELISA optical density readings indicating the production of serum and intestinal antibodies (<jats:italic>P<\/jats:italic>, &lt;0.02 for antipeptide and antilectin antibodies). As a positive control, intranasal immunization with purified recombinant LC3 protein with cholera toxin as the adjuvant elicited a serum anti-LC3 IgA and IgG antibody response (<jats:italic>P<\/jats:italic>, 0.05 and &lt;0.0001, respectively); however, no intestinal anti-LC3 IgA antibody response was observed (<jats:italic>P<\/jats:italic>= 0.4). Of interest, serum IgA and IgG antibodies elicited by the recombinant LC3 vaccine did not recognize any of the four putatively protective LC3 peptide epitopes. Both serum and fecal antibodies elicited by the peptide vaccine exhibited neutralizing activity, as determined by their dose-dependent inhibition of the galactose-specific adherence of<jats:italic>E. histolytica<\/jats:italic>trophozoites to Chinese hamster ovary cells in vitro (<jats:italic>P<\/jats:italic>, &lt;0.001 for each group of antibodies compared to the control). In summary, a lectin-based intranasal polylysine-linked synthetic peptide vaccine was effective in eliciting an adherence-inhibitory, intestinal antilectin IgA antibody response in baboons. Future studies with the baboon model will determine vaccine efficacy against asymptomatic<jats:italic>E. histolytica<\/jats:italic>intestinal infection.<\/jats:p>","DOI":"10.1128\/iai.00341-07","type":"journal-article","created":{"date-parts":[[2007,5,26]],"date-time":"2007-05-26T00:49:37Z","timestamp":1180140577000},"page":"3812-3822","update-policy":"http:\/\/dx.doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":19,"title":["Adherence-Inhibitory Intestinal Immunoglobulin A Antibody Response in Baboons Elicited by Use of a Synthetic Intranasal Lectin-Based Amebiasis Subunit Vaccine"],"prefix":"10.1128","volume":"75","author":[{"given":"Mohamed D.","family":"Abd Alla","sequence":"first","affiliation":[{"name":"Department of Medicine, University of Minnesota, Minneapolis, Minnesota"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary L.","family":"White","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tyson B.","family":"Rogers","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Minnesota, Minneapolis, Minnesota"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Max E.","family":"Cary","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David W.","family":"Carey","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan I.","family":"Ravdin","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Minnesota, Minneapolis, Minnesota"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.02018-05"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.72.7.3974-3980.2004"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/174.1.157"},{"key":"e_1_3_2_5_2","first-page":"2432","volume":"162","year":"1999","unstructured":"Agren, L. C., L. Ekman, B. Lowenadler, J. G. Nedrud, and N. Y. Lycke. 1999. Adjuvanticity of the cholera toxin A1-based gene fusion protein, CTA1-DD, is critically dependent on the ADP-ribosyltransferase and Ig-binding activity. Immunology162:2432-2440.","journal-title":"Immunology"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.73.8.4522-4529.2005"},{"key":"e_1_3_2_7_2","first-page":"537","volume":"13","year":"1978","unstructured":"Atherton, E., H. Fox, C. Harkiss, R. C. Sheppard, and J. Williams. 1978. A mild procedure for solid phase peptide synthesis: use of fluorenylmethoxy carbonyl amino acids. J. Chem. Soc. Chem. Commun.13:537-543.","journal-title":"J. Chem. Soc. Chem. Commun."},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.64.4.1473-1476.1996"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.2002.66.578"},{"key":"e_1_3_2_10_2","unstructured":"Proceedings of the Cold Spring Harbor Conference on Molecular Approaches to Vaccine Design 1999"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI113199"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(02)00043-9"},{"key":"e_1_3_2_13_2","first-page":"480","volume":"35","year":"1964","unstructured":"Cleland, W. W. 1964. Dithiothreitol, a new protective reagent for SH groups. Biochemistry35:480-482.","journal-title":"Biochemistry"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0169-409X(01)00162-4"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/0035-9203(78)90144-X"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.173.5.3310"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1093\/glycob\/cwj007"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(02)00155-X"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.73.9.7780-7786.1999"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/175.3.734"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1086\/320740"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1086\/341566"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2003.09.003"},{"key":"e_1_3_2_24_2","first-page":"153","volume":"21","year":"1990","unstructured":"Jackson, T. F. G. H., P. G. Sargeaunt, P. S. Visser, V. Gathiram, S. Suparsad, and C. B. Anderson. 1990. Entamoeba histolytica: naturally occurring infections in baboons. Arch. Investig. Med.21(Suppl. 1):153-156.","journal-title":"Arch. Investig. Med."},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.74.1.528-536.2006"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.actatropica.2003.12.003"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.72.12.7318-7321.2004"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.185.10.1793"},{"key":"e_1_3_2_29_2","doi-asserted-by":"crossref","first-page":"4621","DOI":"10.4049\/jimmunol.155.10.4621","volume":"155","year":"1995","unstructured":"Marinaro, M., H. F. Staats, T. Hiroi, R. J. Jackson, M. Coste, P. N. Boyaka, et al. 1995. Mucosal adjuvant effect of cholera toxin in mice results from induction of T helper 2 (Th2) cells and IL-4. J. Immunol.155:4621-4629.","journal-title":"J. Immunol."},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1462-5822.2004.00363.x"},{"key":"e_1_3_2_31_2","first-page":"371","year":"2005","unstructured":"McGhee, J. R., and W. Strober. 2005. Mucosal immunology, 3rd ed., p. 371-373. Elsevier Academic Press, London, United Kingdom.","journal-title":"Mucosal immunology"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-3659(97)00036-9"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI113198"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.59.1.97-101.1991"},{"key":"e_1_3_2_35_2","doi-asserted-by":"crossref","first-page":"4803","DOI":"10.4049\/jimmunol.144.12.4803","volume":"144","year":"1990","unstructured":"Petri, W. A., Jr., T. L. Snodgrass, T. F. G. H. Jackson, et al. 1990. Monoclonal antibodies directed against the galactose-binding lectin of Entamoeba histolytica enhance adherence. J. Immunol.144:4803-4809.","journal-title":"J. Immunol."},{"key":"e_1_3_2_36_2","first-page":"3097","year":"2005","unstructured":"Ravdin, J. I., and W. Stauffer. 2005. Entamoeba histolytica (amebiasis), p. 3097-3111. In G. L. Mandell, J. E. Bennett, and R. Dolin (ed.), Principles and practice of infectious diseases, 6th ed. Churchill Livingstone, Inc., New York, NY.","journal-title":"Principles and practice of infectious diseases"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.71.12.6899-6905.2003"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI110377"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/162.3.768"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1128\/CDLI.6.6.953-958.1999"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/171.3.645"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(88)91355-4"},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00436-002-0808-z"},{"key":"e_1_3_2_44_2","first-page":"93","year":"1988","unstructured":"Walsh, J. A. 1988. Prevalence of Entamoeba histolytica infection, p. 93-105. In J. I. Ravdin (ed.), Amebiasis: human infection by Entamoeba histolytica. Churchill Livingstone, New York, NY.","journal-title":"Amebiasis: human infection by Entamoeba histolytica"},{"key":"e_1_3_2_45_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02786362"},{"key":"e_1_3_2_46_2","first-page":"225","volume":"62","year":"1995","unstructured":"Zhang, T., E. Li, and S. L. Stanley, Jr. 1995. Protection of gerbils from amebic liver abscess by immunization with a recombinant Entamoeba histolytica antigen. Infect. Immun.62:225-230.","journal-title":"Infect. Immun."},{"key":"e_1_3_2_47_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.70.10.5873-5876.2002"}],"container-title":["Infection and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/IAI.00341-07","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/IAI.00341-07","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,12]],"date-time":"2023-05-12T01:13:11Z","timestamp":1683853991000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/IAI.00341-07"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8]]},"references-count":46,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2007,8]]}},"alternative-id":["10.1128\/IAI.00341-07"],"URL":"https:\/\/doi.org\/10.1128\/iai.00341-07","relation":{},"ISSN":["0019-9567","1098-5522"],"issn-type":[{"value":"0019-9567","type":"print"},{"value":"1098-5522","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,8]]},"assertion":[{"value":"2007-03-05","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2007-05-19","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2007-08-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}